I agree that this site is using cookies. You can find further informations here.
X
Gafanov, Rustem
12  results:
Search for persons X
?
1

Pembrolizumab Plus Axitinib Versus Sunitinib as First-line ..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  84 (2023)  5 - p. 449-454 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  84 (2023)  5 - p. e123-e124 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  , 2023
Link: https://doi.org/10.1016/..
 
?
4

Health-related Quality of Life Analysis from KEYNOTE-426: P..:

Bedke, Jens ; Rini, Brian I. ; Plimack, Elizabeth R....
European Urology.  82 (2022)  4 - p. 427-439 , 2022
Link: https://doi.org/10.1016/..
 
?
5

KEYNOTE-921: Phase III Study of Pembrolizumab Plus Docetaxe..:

Petrylak, Daniel P ; Ratta, Raffaele ; Gafanov, Rustem...
Future Oncology.  17 (2021)  25 - p. 3291-3299 , 2021
Link: https://doi.org/10.2217/..
 
?
6

Ipatasertib plus abiraterone and prednisolone in metastatic..:

Sweeney, Christopher ; Bracarda, Sergio ; Sternberg, Cora N...
The Lancet.  398 (2021)  10295 - p. 131-142 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Nivolumab in patients with metastatic renal cell carcinoma ..:

Tsimafeyeu, Ilya ; Gafanov, Rustem ; Protsenko, Svetlana...
Cancer Immunology, Immunotherapy.  69 (2020)  6 - p. 983-988 , 2020
Link: https://doi.org/10.1007/..
 
?
8

Open-Label, Single-Arm Phase II Study of Pembrolizumab Mono..:

McDermott, David F ; Lee, Jae Lyun ; Bjarnason, Georg A...
McDermott , D F , Lee , J L , Bjarnason , G A , Larkin , J M G , Gafanov , R A , Kochenderfer , M D , Jensen , N V , Donskov , F , Malik , J , Poprach , A , Tykodi , S S , Alonso-Gordoa , T , Cho , D C , Geertsen , P F , Climent Duran , M A , DiSimone , C , Silverman , R K , Perini , R F , Schloss , C & Atkins , M B 2021 , ' Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma ' , Journal of clinical oncology : official journal of the American Society of Clinical Oncology , vol. 39 , no. 9 , pp. 1020-1028 . https://doi.org/10.1200/JCO.20.02363.  , 2021
Link: https://portal.findresea..
 
?
9

Open-Label, Single-Arm Phase II Study of Pembrolizumab Mono..:

McDermott, David F ; Lee, Jae-Lyun ; Bjarnason, Georg A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078336/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Open-Label, Single-Arm Phase II Study of Pembrolizumab Mono..:

McDermott, David F ; Lee, Jae Lyun ; Bjarnason, Georg A...
McDermott , D F , Lee , J L , Bjarnason , G A , Larkin , J M G , Gafanov , R A , Kochenderfer , M D , Jensen , N V , Donskov , F , Malik , J , Poprach , A , Tykodi , S S , Alonso-Gordoa , T , Cho , D C , Geertsen , P F , Climent Duran , M A , DiSimone , C , Silverman , R K , Perini , R F , Schloss , C & Atkins , M B 2021 , ' Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma ' , Journal of Clinical Oncology , vol. 39 , no. 9 , pp. 1020-1028 . https://doi.org/10.1200/JCO.20.02363.  , 2021
Link: https://pure.au.dk/porta..
 
?
11

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Mon..:

McDermott, David F ; Lee, Jae-Lyun ; Ziobro, Marek...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078262/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

First-line pembrolizumab (pembro) monotherapy in advanced c..:

McDermott, David F ; Lee, Jae-Lyun ; Bjarnason, Georg A...
McDermott , D F , Lee , J-L , Bjarnason , G A , Larkin , J M G , Gafanov , R A , Kochenderfer , M D , Jensen , N V , Donskov , F , Malik , J , Poprach , A , Tykodi , S S , Gordoa , T A , Cho , D C , Geertsen , P F , Duran , M A C , Simone , C D , Du , X , Perini , R F , Rodriguez-Lopez , K & Atkins , M B 2020 , ' First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A. ' , Journal of Clinical Oncology , vol. 38 , no. Suppl. 15 , 5069 . https://doi.org/10.1200/JCO.2020.38.15_suppl.5069.  , 2020
Link: https://portal.findresea..
 
1-12